Functionalised High‐Performance Oxide Ceramics with Bone Morphogenic Protein 2 (BMP‐2) Induced Ossification: An In Vivo Study

This study investigated the in vivo osseointegration potential of high‐performance oxide ceramics (HPOCs) with peptide bone morphogenic protein 2 (BMP‐2), comparing them with titanium implants. Histomorphometry was conducted around the distal, proximal, medial, and lateral sides of the implants to quantify the amount of mature and immature ossification within the bone interface. We hypothesised that HPOCs functionalised with BMP‐2 promote ossification. HPOCs functionalised with BMP‐2 were manufactured at the Department of Dental Materials Science and Biomaterial Research of the RWTH University Aachen, Germany. Histomorphometry was conducted by a professional pathologist in all samples. The region of interest (ROI) represented the percentage of the surrounding area of the implant. The percentages of ROI covered by osteoid implant contact (OIC) and mature bone–implant contact (BIC) were assessed. The surrounding presence of bone resorption, necrosis, and/or inflammation was quantitatively investigated. A total of 36 rabbits were used for the experiments. No bone resorption, necrosis, or inflammation was found in any sample. At the 12‐week follow‐up, the overall BIC was significantly increased (p < 0.0001). No improvement was evidenced in OIC (p = 0.6). At the 6‐week follow‐up, the overall OIC was greater in the BMP‐2 compared to the titanium group (p = 0.002). The other endpoints of interest evidenced similarity between the two implants at various follow‐up time points (p > 0.05). In con-clusion, alumina HPOCs functionalised with peptide BMP‐2 promote in vivo ossification in a simi-lar fashion to titanium implants.